| Misonix designs, manufactures and markets minimally invasive surgical ultrasonic medical devices. These products include BoneScalpel Surgical System, which is used for surgical procedures involving the cutting and sculpting of bone while sparing soft tissue; SonaStar Surgical Aspirator, which is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery fields; and SonicOne Wound Debridement System, which provides tissue debridement and cleansing of wounds and burns for removal of devitalized tissue and fibrin deposits while sparing viable cells. These devices primarily serve the following clinical areas: neurosurgery, wound care and maxillo-facial surgery. We show 46 historical shares outstanding datapoints in our coverage of MSON's shares outstanding history.|
Understanding the changing numbers of MSON shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MSON versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MSON by allowing them to research MSON shares outstanding history
as well as any other stock in our coverage universe.